These genes are strongly associated with cancer risk and may have clear clinical actionability, supporting the goal that each addition to the panel provides meaningful insights for patient care. The ...

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, and ...

Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...

Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

OncoCyte Corp ( ($IMDX) ) has released its Q3 earnings. Here is a breakdown of the information OncoCyte Corp presented to its investors. Insight ...

PARSIPPANY, NJ, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the final Local ...

BOSTON, Nov. 10, 2025 /PRNewswire/ -- Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its ...

The allergy diagnostics market is fueled by growing awareness of personalized treatment options, and the integration of high-sensitivity molecular diagnostic platforms.Hyderabad, Nov. 13, 2025 (GLOBE ...

The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...

NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $10.9 million in its third quarter. On a per-share basis, the Nashville, ...